Search Filters

Aerosol-generating procedures and risk of SARS-CoV-2

Status: Published on

To inform national efforts in response to COVID-19, HIQA is developing evidence summaries to answer specific research questions posed by the National Public Health Emergency Team, as well as those developing infection prevention and control guidance in their response to COVID-19.



This summary details the best available evidence to answer the following question: Is performing aerosol generating procedures (AGPs) on patients without clinical features of viral respiratory tract infections associated with airborne transmission to healthcare professionals?

Supporting documents